[go: up one dir, main page]

CY1109328T1 - Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου - Google Patents

Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου

Info

Publication number
CY1109328T1
CY1109328T1 CY20091100888T CY091100888T CY1109328T1 CY 1109328 T1 CY1109328 T1 CY 1109328T1 CY 20091100888 T CY20091100888 T CY 20091100888T CY 091100888 T CY091100888 T CY 091100888T CY 1109328 T1 CY1109328 T1 CY 1109328T1
Authority
CY
Cyprus
Prior art keywords
compounds
tumor
thienodibenzoazulenium
necrosion
factor inhibitors
Prior art date
Application number
CY20091100888T
Other languages
English (en)
Inventor
Mladen Mercep
Milan Mesic
Dijana Pesic
Zeljko Zupanovic
Boska Hrvacic
Original Assignee
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. filed Critical Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.
Publication of CY1109328T1 publication Critical patent/CY1109328T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Η παρούσα εφεύρεση αφορά τις νέες ενώσεις διβενζοαζουλενίου που αντιπροσωπεύονται από τον τύπο I, καθώς και τα φαρμακευτικά παρασκευάσματα αυτών για την αναστολή του άλφα παράγοντα νέκρωσης όγκου (TNF-α) και της ιντερλευκίνης 1 (IL-1) σε θηλαστικά σε όλες τις ασθένειες και καταστάσεις όπου αυτοί οι μεσολαβητές εκκρίνονται υπερβολικά. Οι ενώσεις της παρούσας εφεύρεσης επίσης παρουσιάζουν αναλγητική δράση και μπορεί να χρησιμοποιούνται για την ανακούφιση πόνου.
CY20091100888T 2000-05-17 2009-08-20 Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου CY1109328T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20000310A HRP20000310A2 (en) 2000-05-17 2000-05-17 New dibenzoazulene compounds as tumor necrosis factor inhibitors
PCT/HR2001/000027 WO2001087890A1 (en) 2000-05-17 2001-05-16 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors

Publications (1)

Publication Number Publication Date
CY1109328T1 true CY1109328T1 (el) 2012-05-23

Family

ID=10947110

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100888T CY1109328T1 (el) 2000-05-17 2009-08-20 Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου

Country Status (36)

Country Link
US (2) US6897211B2 (el)
EP (1) EP1284977B1 (el)
JP (1) JP2003533528A (el)
KR (1) KR100823064B1 (el)
CN (1) CN1194976C (el)
AR (1) AR030562A1 (el)
AT (1) ATE434619T1 (el)
AU (2) AU2001256560B2 (el)
BG (1) BG65967B1 (el)
BR (1) BR0111202A (el)
CA (1) CA2409090C (el)
CR (1) CR6860A (el)
CY (1) CY1109328T1 (el)
CZ (1) CZ301770B6 (el)
DE (1) DE60139070D1 (el)
DK (1) DK1284977T3 (el)
DZ (1) DZ3357A1 (el)
EA (1) EA006069B1 (el)
EE (1) EE200200636A (el)
ES (1) ES2328335T3 (el)
GE (1) GEP20043304B (el)
HR (1) HRP20000310A2 (el)
HU (1) HUP0302295A3 (el)
IL (1) IL152809A0 (el)
IS (1) IS6621A (el)
MA (1) MA27125A1 (el)
MX (1) MXPA02011269A (el)
NO (1) NO20025510L (el)
NZ (1) NZ522553A (el)
PL (1) PL204849B1 (el)
PT (1) PT1284977E (el)
RS (1) RS50893B (el)
SI (1) SI1284977T1 (el)
SK (1) SK17702002A3 (el)
WO (1) WO2001087890A1 (el)
ZA (1) ZA200209180B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020305A8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020303B8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020440B1 (en) * 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020441A2 (en) * 2002-05-21 2003-12-31 Pliva D D 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020453A2 (en) 2002-05-23 2003-12-31 Pliva D D 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020452A2 (en) * 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20020451A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
US20090018351A1 (en) * 2003-11-12 2009-01-15 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
WO2006046123A2 (en) 2004-10-27 2006-05-04 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugates with anti-inflammatory activity
CA2588760C (en) * 2004-12-07 2014-05-13 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives
JP2008532927A (ja) * 2005-01-13 2008-08-21 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗炎症マクロライド接合体
DK2026651T3 (da) 2006-03-08 2013-07-08 Cortria Corp Kombinationsterapi med ikke-selektive COX-inhibitorer til forebyggelse af COX-relaterede maveskader
US8389482B2 (en) 2007-01-30 2013-03-05 New York University Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species
WO2008096755A1 (ja) * 2007-02-07 2008-08-14 Nippon Suisan Kaisha, Ltd. バニロイド受容体（ｖｒ１）阻害剤及びその用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
JPS53116385A (en) * 1977-03-19 1978-10-11 Hokuriku Pharmaceutical Pyrazin derivative and method for its production
US4198421A (en) * 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
NZ329953A (en) * 1996-04-12 1999-06-29 Janssen Pharmaceutica Nv Substituted tetracyclic n-oxide tetrahydrofuran derivatives, salts and stereoisomeric forms thereof for the treatment of cns cardiovascular or gastrointestinal disorders
GB9713368D0 (en) * 1997-06-25 1997-08-27 Weston Medical Ltd Flame control
EP0887339A1 (de) * 1997-06-27 1998-12-30 Roche Diagnostics GmbH Neue Azulenderivate und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
IL152809A0 (en) 2003-06-24
CR6860A (es) 2008-06-02
US20050171091A1 (en) 2005-08-04
CN1437605A (zh) 2003-08-20
US20030153750A1 (en) 2003-08-14
RS50893B (sr) 2010-08-31
NO20025510L (no) 2003-01-14
EP1284977A1 (en) 2003-02-26
DZ3357A1 (fr) 2001-11-22
PL204849B1 (pl) 2010-02-26
MXPA02011269A (es) 2003-06-06
DE60139070D1 (de) 2009-08-06
JP2003533528A (ja) 2003-11-11
BG107399A (bg) 2003-09-30
CZ301770B6 (cs) 2010-06-16
PT1284977E (pt) 2009-09-09
EA200201223A1 (ru) 2003-06-26
HK1056719A1 (en) 2004-02-27
EP1284977B1 (en) 2009-06-24
SK17702002A3 (sk) 2003-10-07
KR100823064B1 (ko) 2008-04-18
ATE434619T1 (de) 2009-07-15
NO20025510D0 (no) 2002-11-15
AR030562A1 (es) 2003-08-27
PL365054A1 (en) 2004-12-27
CZ20024090A3 (cs) 2003-05-14
HUP0302295A3 (en) 2007-03-28
ES2328335T3 (es) 2009-11-12
HUP0302295A2 (hu) 2003-10-28
YU84102A (sh) 2006-01-16
MA27125A1 (fr) 2005-01-03
GEP20043304B (en) 2004-02-10
SI1284977T1 (sl) 2009-10-31
BR0111202A (pt) 2003-04-01
KR20030010625A (ko) 2003-02-05
AU5656001A (en) 2001-11-26
BG65967B1 (bg) 2010-07-30
DK1284977T3 (da) 2009-09-14
EA006069B1 (ru) 2005-08-25
HRP20000310A2 (en) 2002-02-28
WO2001087890A1 (en) 2001-11-22
CN1194976C (zh) 2005-03-30
AU2001256560B2 (en) 2005-10-06
IS6621A (is) 2002-11-14
CA2409090A1 (en) 2001-11-22
ZA200209180B (en) 2003-11-12
CA2409090C (en) 2010-06-29
NZ522553A (en) 2005-04-29
US6897211B2 (en) 2005-05-24
EE200200636A (et) 2004-04-15

Similar Documents

Publication Publication Date Title
CY1109328T1 (el) Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου
EA200400648A1 (ru) N, n'-замещенные производные 1,3-диамино-2-гидроксипропана
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
TR200103493T2 (tr) Metaloproteaz önleyicileri
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200001224A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200400595A1 (ru) Бензимидазолы, применяемые в качестве ингибиторов протеинкиназы
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
ATE452884T1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
EA200200625A1 (ru) Антипикорнавирусные соединения и композиции, их фармацевтическое применение и вещества для их синтеза
SE9903894D0 (sv) Novel compounds
NO922133D0 (no) Substituerte diaminoftalimider og analoger
ATE451922T1 (de) Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren
ATE453614T1 (de) Sphingolipiden
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
SE0004827D0 (sv) Therapeutic compounds
EA200400709A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
NO972906D0 (no) 4,4-(Disubstituerte)cykloheksan-1-ol-monomerer og beslektede forbindelser
FI972673A7 (fi) 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdiste itä
DE60120398D1 (de) Imidazopyridin-8-one